This study on stage III rectal cancer aims to 
1. compare the survival outcome (os, rfs) in patients with stage 3 rectal cancer managed with either surveillance or adjuvant chemotherapy after surgical excision.
2. Investigate if the survival difference in 1 is influenced by any confounding factors
